Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.
about
Herbal medicines and nonalcoholic fatty liver diseaseApplication of Herbal Medicines with Bitter Flavor and Cold Property on Treating Diabetes MellitusMetformin and metabolic diseases: a focus on hepatic aspectsGenetic evidence for inhibition of bacterial division protein FtsZ by berberineComprehensive study in the inhibitory effect of berberine on gene transcription, including TATA boxBerberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesisTherapeutic Effect of Berberine on Huntington's Disease Transgenic Mouse ModelBerberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 PathwayDietary and nutraceutical approach to type 2 diabetes.A review of the effects of Berberis vulgaris and its major component, berberine, in metabolic syndromeActivation of AMP-activated protein kinase is required for berberine-induced reduction of atherosclerosis in mice: the role of uncoupling protein 2.Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis.Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed ratsCardiovascular and metabolic effects of Berberine.Anti-hyperlipidemic and anti-oxidative effects of gelsemine in high-fat-diet-fed rabbits.Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes.Berberine regulated Gck, G6pc, Pck1 and Srebp-1c expression and activated AMP-activated protein kinase in primary rat hepatocytes.Tissue distribution of berberine and its metabolites after oral administration in rats.Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profilesClinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statinsApproaches to improve the oral bioavailability and effects of novel anticancer drugs berberine and betulinic acid.Potential benefits of berberine in the management of perimenopausal syndrome.Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus.Application of berberine on treating type 2 diabetes mellitus.Insulin resistance: Is it time for primary prevention?Transforming berberine into its intestine-absorbable form by the gut microbiotaBerberine improves insulin sensitivity by inhibiting fat store and adjusting adipokines profile in human preadipocytes and metabolic syndrome patientsA nutraceutical combination improves insulin sensitivity in patients with metabolic syndromeBerberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice.Berberine reverses abnormal expression of L-type pyruvate kinase by DNA demethylation and histone acetylation in the livers of the non-alcoholic fatty disease rat.Berberine sensitizes mutliple human cancer cells to the anticancer effects of doxorubicin in vitroDeciphering the therapeutic mechanisms of Xiao-Ke-An in treatment of type 2 diabetes in mice by a Fangjiomics approach.Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic controlFructus mume formula in the treatment of type 2 diabetes mellitus: a randomized controlled pilot trial.The rs1142345 in TPMT Affects the Therapeutic Effect of Traditional Hypoglycemic Herbs in Prediabetes.Update on berberine in nonalcoholic Fatty liver disease.A blend of phellodendron and crape myrtle improves glucose tolerance in exercise-trained menBeneficial Effects of Berberine on Oxidized LDL-Induced Cytotoxicity to Human Retinal Müller Cells.Leukocytes from diabetic patients kill retinal endothelial cells: effects of berberine.Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes.
P2860
Q26738524-4525EEF0-7B18-47B1-9984-C9F586FB1BB6Q26777931-FF7E11BD-16F0-4444-8E18-48B3BA35728AQ28082736-F3A77B7C-42B7-43C8-9313-F5794C71837EQ28475965-EEBFB14A-DBE5-4271-B7B1-9B59336D5BA7Q28476688-C6666629-D1DB-4046-998A-9A28ABD7B638Q28477076-46D44D6F-5141-4DC5-80BD-97F1ECF700E3Q28546885-93E15A98-F3E9-4048-993C-2784D2F42002Q28550972-3769490E-1697-48B5-84E0-A2AADF30889EQ33701311-F05FA530-374B-477B-BBB5-BA838AB17989Q33819610-A30822E1-84F1-4EA0-83E4-F6CDA2474E92Q34043189-16721687-64B2-4648-879B-2C549863BE9FQ34309558-40D43447-5FAA-4B75-AEAF-FC6C961A1300Q34374252-3D25F06A-0353-40EA-B015-BFFF959E94DCQ34390654-C6DD099D-131A-47B3-A0E1-C2E5D844EDE3Q34438111-5B028FA1-EB4B-43BC-93D1-841264315C23Q35011317-1E38C28B-DD2D-4C0D-AB48-31E252134390Q35022545-AE8BB12D-6F8A-47D4-A1B7-7BE9ADED2C96Q35035856-E51562D0-39EE-47C7-B347-EA74E0D8E345Q35047942-5B83FCE3-D9FB-4A97-8537-7EC4E000FBFCQ35067558-4262317E-C8CE-4D90-8CC3-A0FE8CDE8FD4Q35116352-61093B19-06A9-420D-B0BD-ED1819BFD099Q35138347-1EF49C02-47C0-41B5-B2F4-0E115C8E6515Q35145862-09F1B40A-D9BB-43D8-80DB-2CACA61D7438Q35226998-9CFF963B-8289-4AF2-A6A0-DE550591038AQ35683999-3BAB6274-5309-44B4-97C6-E115963EB372Q35691271-F6AC2E91-0FA7-4AE9-A4DE-E18B16606659Q35846030-5877EA8E-E6A3-48D3-9F71-ADE1B68AF8C0Q35852504-B14ACBFF-F57F-43A9-BB4C-0C070AE0594EQ35858819-8969E28B-1A57-4DE3-88CE-BAB7A703E7AEQ35870837-12DC0FC8-946C-444A-A79D-BB97ED67A859Q36084357-CC191B2C-2D6D-40EF-B8AC-406742001278Q36123951-01458151-CEAE-4389-AB6A-D239451E7477Q36175416-2F72E14A-4868-4271-9493-83D6C4D19165Q36711563-9A2F7A60-D93E-4AF9-ACCE-8BE2B8C58DE3Q36853578-324FBE76-4D99-4127-8262-3D55590B22D8Q36988577-A3FA5F2E-98E7-4F21-AA66-03C077E1E5AFQ37082801-9F98A657-A750-40AC-B06C-3D235B28ADD9Q37126456-975D5777-5C13-4A39-A8D5-055FF337161BQ37238931-C725AE05-DC76-4CA8-9307-43B894D17B28Q37337259-43070841-CA1F-426E-BE63-B057899BD3F9
P2860
Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Berberine lowers blood glucose ...... g insulin receptor expression.
@en
Berberine lowers blood glucose ...... g insulin receptor expression.
@nl
type
label
Berberine lowers blood glucose ...... g insulin receptor expression.
@en
Berberine lowers blood glucose ...... g insulin receptor expression.
@nl
prefLabel
Berberine lowers blood glucose ...... g insulin receptor expression.
@en
Berberine lowers blood glucose ...... g insulin receptor expression.
@nl
P2093
P921
P1433
P1476
Berberine lowers blood glucose ...... g insulin receptor expression.
@en
P2093
Dan-Qing Song
Huai-Ning Pan
Jian-Dong Jiang
Jin-Dan Wu
Shu-Kui Wang
Wei-Jia Kong
P304
P356
10.1016/J.METABOL.2009.07.029
P577
2009-10-01T00:00:00Z